CLINICAL_TRIALS
trial_result
· 2020-04-15
Clinical Trial Update: Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Summary
Phase 2 trial update of decitabine in older or unfit patients with acute myeloid leukemia (AML) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-04-15